Benevides L, da Fonseca DM, Donate PB, Tiezzi DG, De Carvalho DD, de Andrade JM, Martins GA, Silva JS. IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Res. 2015;75(18):3788-3799. http://cancerres.aacrjournals.org/content/75/18/3788.
Salehi S, Benevides L, Willen J, Keech N, Dhall D, Meffre E, Targan S, Martins G. B lymphocyte–induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17–producing CD4+ T Cells. J Immunol. 2012;189(12):5682-5693. http://www.jimmunol.org/content/189/12/5682.
Rutishauser RL, Martins GA, Kalachikov S, Chandele A, Parish IA, Meffre E, Jacob J, Calame K, Kaech SM. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity. 2009;31(2):296-308. http://www.cell.com/immunity/abstract/S1074-7613(09)00323-9.
Martins GA, Cimmino L, Liao J, Magnusdottir E, Calame K. Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival. J Exp Med. 2008;205(9):1959-1965. http://jem.rupress.org/content/205/9/1959.
Cimmino L, Martins GA, Liao J, Magnusdottir E, Grunig G, Perez RK, Calame KL. Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression. J Immunol. 2008;181(4):2338-2347. http://www.jimmunol.org/content/181/4/2338.
de Moraes LV, Bueno V, Marguti I, Martins GA, Vallochi AL, Yamamoto GL, Panajotopoulos N, Mengel JO, Rizzo LV. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation. Transpl Immunol. 2008;18(4):330-337. http://www.sciencedirect.com/science/article/pii/S096632740700158X.
Martins GA, Hutchins A, Reiner SL. Transcriptional activators of helper T cell fate are required for establishment but not maintenance of signature cytokine expression. J Immunol. 2005;175(9):5981-5985. http://www.jimmunol.org/content/175/9/5981.
Martins GA, Tadokoro CE, Silva RB, Silva JS, Rizzo LV. CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi. J Immunol. 2004;172(8):4893-4901. http://www.jimmunol.org/content/172/8/4893.
Martins GA, Vieira LQ, Cunha, FQ, Silva JS. Gamma interferon modulates CD95 (Fas) and CD95 ligand (FasL) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect Immun. 1999;67(8):3864-3871. http://iai.asm.org/content/67/8/3864.abstract.
Contact the Martins Lab
110 N. George Burns Road Davis Building, Room 4094C Los Angeles, CA 90048
This website converts English to other languages using an automated tool called Microsoft Translator™. The translations may include errors or change the intended meaning of the text. Please consult your healthcare provider about any medical information.
Translations may not be available for some items, including PDF documents, maps, video captions, and text that appears on photos. Also, some features on the website may not work in the translated versions.
This Web page converts English to other languages â â using an automated tool called Microsoft Translatorâ ¢. Translations may include errors or change the intended meaning of the text. Please consult your doctor about any medical information.
Translations may not be available for some articles, including PDF documents, maps, video legends and text that appears in the photos. Also, some of the features on the website may not work in the translated versions.